Medical Devices and Diagnostics

MH2 has substantial expertise assisting premier companies and university systems to strategically capture important innovations across the spectrum of medical devices and diagnostics. This spectrum spans a diverse array of surgical tools, medical consumables, implant devices, and point-of-care apparatus. Additional illustrations include complex automated laboratory systems that increasingly integrate artificial intelligence (AI)-based data analysis pipelines and other software related implementations to effectuate infectious disease and oncological detection, among other diagnostic targets. These approaches leverage many different underlying biochemical technologies, including next generation nucleic acid sequencing (NGS), nucleic acid amplification, immunochemistry, and proteomics, among a host of other techniques.